Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer

被引：0
|
作者：
Choi, Sung-eun
Pyo, Ju Yeon
Kim, Ji-seop
Shin, Eunah
Hong, Soon W.
机构：
[1] Gangnam Severance Hosp, Seoul, South Korea
[2] Hanyang Univ, Guri Hosp, Guri Si, Kyeonggi Do, South Korea
[3] CHA Gangnam Hosp, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
576
引用
收藏
页码：147A / 148A
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
    Worden, Francis
    Fassnacht, Martin
    Shi, Yuankai
    Hadjieva, Tatiana
    Bonichon, Franoise
    Gao, Ming
    Fugazzola, Laura
    Ando, Yuichi
    Hasegawa, Yasuhisa
    Park, Do Joon
    Shong, Young Kee
    Smit, Johannes W. A.
    Chung, John
    Kappeler, Christian
    Meinhardt, Gerold
    Schlumberger, Martin
    Brose, Marcia S.
    [J]. ENDOCRINE-RELATED CANCER, 2015, 22 (06) : 877 - 887
  • [22] Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer
    Hewett, Yvonne
    Ghimire, Subash
    Farooqi, Bilal
    Shah, Binay K.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 28 - 32
  • [23] THE EVPI OF TREATMENT STRATEGIES FOR RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Huang, W.
    Chen, L.
    Ting, J.
    Cao, V
    Sung, H.
    Yokokura, M.
    Wilson, L.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A886 - A886
  • [24] New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
    Wong, Kai-Pun
    Lang, Brian Hung-Hin
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [25] Targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer (DTC)
    Herceg, Davorin
    Herceg, Gordana Horvatic
    [J]. PERIODICUM BIOLOGORUM, 2014, 116 (04) : 399 - 407
  • [26] Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer
    Weitzman, Steven P.
    Sherman, Steven, I
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 253 - +
  • [27] Treatment of Patients with Radioiodine-Refractory, differentiated Thyroid Cancer A Consensus Statement
    Lindner, C.
    Dierneder, J.
    Pall, G.
    Pirich, C.
    Hoffmann, M.
    Raderer, M.
    Becherer, A.
    Niederle, B.
    Lipp, R.
    Lind, P.
    Gallowitsch, H.
    Romeder, F.
    Virgolini, I.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 125 - 130
  • [28] Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
    So Won Oh
    Seung-hwan Moon
    Do Joon Park
    Bo Youn Cho
    Kyeong Cheon Jung
    Dong Soo Lee
    June-Key Chung
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1798 - 1805
  • [29] Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyond
    Bulotta, Stefania
    Celano, Marilena
    Costante, Giuseppe
    Russo, Diego
    [J]. CURRENT OPINION IN ONCOLOGY, 2020, 32 (01) : 13 - 19
  • [30] Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
    Oh, So Won
    Moon, Seung-hwan
    Park, Do Joon
    Cho, Bo Youn
    Jung, Kyeong Cheon
    Lee, Dong Soo
    Chung, June-Key
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (10) : 1798 - 1805
12345